It is found that a SVVYGLR peptide can stimulate the proliferation of a mesenchymal cell such as a marrow-derived mesenchymal stem cell and a dental pulp cell.

Also disclosed are a method for cultivation of a mesenchymal stem cell, a method for isolation of a mesenchymal stem cell, and a culture medium, vessel or sheet for use in the cultivation of a mesenchymal stem cell.

The umbilical mesenchymal stem cell may be transformed with an oncogene such as c-myc.

The method comprises administrating an effective amount of a human mesenchymal stem cell to a patient.

After 4 weeks, the mesenchymal stem cell sheet is transplanted into the heart of the animals.

Disclosed are: a mesenchymal stem cell inducer which can induce a mesenchymal stem cell; and others.

A cell which is a mesenchymal stem cell precursor having been differentiated from a pluripotent stem cell in vitro and being Sox1-positive, and a method of preparing the same.

Thus, a means of differentiating a mesenchymal stem cell into a matured liver cell has been developed.

The human hybrid stem cell produced by transplanting the nucleus of a human mesenchyme stem cell into the enucleated pig oocyte is also disclosed.

In particular, the present invention relates to an isolated mesenchymal connective tissue-derived stem cell.

The method can further include contacting the mesenchymal stem cell with interferon-η.

A gene shown in Sequence Listing is expressed specifically in a mesenchymal stem cell.

In one embodiment, the culturing of the mesenchymal stem cell is achieved by means of three-dimensional culturing.

Disclosed is a method for producing a mesenchymal stem cell capable of being differentiated into a myoblast by culturing a pluripotent stem cell derived from a human body or an animal.

One or more specific examples of the present invention relate to a mesenchymal stem cell incorporating a nucleotide sequence coding TGFβ, and to the uses thereof.